tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$50.45
HK$17.10B
149.75%
0 Buy
0 Hold
0 Sell
Hold
Sino Biopharmaceutical
$0.64
$12.03B
49.32
83.14%
3 Buy
1 Hold
0 Sell
Strong Buy
CSPC Pharmaceutical Group
$1.15
$12.82B
19.73
29.63%
5 Buy
2 Hold
1 Sell
Moderate Buy
3SBio
$2.95
$7.04B
25.04
268.75%
3 Buy
1 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
$3.25
$13.74B
28.61
111.04%
7 Buy
2 Hold
0 Sell
Strong Buy
Netease Inc
HK$204.60
HK$643.09B
18.97
49.56%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
50.45
29.75
143.72%
SBMFF
Sino Biopharmaceutical
0.64
0.30
88.24%
CHJTF
CSPC Pharmaceutical Group
1.05
0.26
32.91%
TRSBF
3SBio
2.95
2.17
278.21%
WXIBF
Wuxi Biologics (Cayman)
3.25
1.71
111.04%
HK:9999
Netease Inc
204.60
63.13
44.62%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis